SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
shopping cart loaded with pills with dollar signs around it on a light blue background
Opinion
Drug Price Transparency in US Is Easier Said Than Done
A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque. But drug companies and other stakeholders would reap the benefits of such disclosures.
May 28, 2025
 · 
6 min read
 · 
Dennis Sponer
Loss of one drug name. Ban on a drug or its shortage. Exclusion from the list of free drugs available under the medical social program.
Rare diseases
InflaRx Axes Rare Skin Disease Study on Disappointing Late-Stage Data
InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.
May 28, 2025
 · 
2 min read
 · 
Tristan Manalac
Medical syringe and bottle with liquid drug in continuous line art drawing style. Treatment, immunization and vaccination minimalist design. Vector illustration
Vaccines
RFK Jr. Removes CDC COVID Vaccine Recommendation for Healthy Children, Pregnant Women
In a video posted to social media on Tuesday, HHS Secretary Robert F. Kennedy, Jr. claimed that there is a lack of clinical data to support the repeat COVID-19 booster strategy in children.
May 28, 2025
 · 
3 min read
 · 
Tristan Manalac
Illustration of a group of businessmen white-collar workers dismissed
Layoffs
AbbVie’s Allergan Cuts Over 200 Staff After Botched Marketing Campaign
The layoffs will take effect on July 22 and particularly target those working in sales, data engineering and product management.
May 28, 2025
 · 
2 min read
 · 
Tristan Manalac
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
Former Chinook Board Member Indicted for Insider Trading Related to $3.2B Novartis Buy
Rouzbeh Haghighat was serving on the board of Chinook Therapeutics at the time of the Novartis acquisition and, according to the DOJ’s allegations, used confidential information to conduct insider trading.
May 28, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
COVID-19 Vaccine Overhaul, Rocket Grounded, ‘One Tough Hombre’ on MFN
HHS Secretary RFK Jr. removes the COVID-19 vaccine recommendation for healthy kids and pregnant women—the latest in a string of changes to vaccine policies; judge issues an order to halt HHS’ reorganization and mass layoff plans; Rocket Pharmaceuticals’ pivotal Danon disease trial is on hold after a patient death; and President Trump has named Mehmet Oz to spearhead his Most Favored Nation drug pricing policy.
May 28, 2025
 · 
2 min read
 · 
Heather McKenzie
Depressed woman with flying hair stand in the choppy water. Lost girl feels frustrated and confused thinking. Concept of psychological problem, mental disease and brain illness. Vector illustration.
Depression
Biogen’s Zurzuvae Strategy Shifts as OB/GYNs Rise to the Front Lines
Nearly two years in with Zurzuvae, Biogen tackles an ‘all of the above market’ to find patients and battle stigma in postpartum depression.
May 28, 2025
 · 
5 min read
 · 
Annalee Armstrong
Perspective way to invest money. Hands with dollar sign coins around yellow light bulb over blue background
Clinical research
Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond
R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.
May 28, 2025
 · 
12 min read
 · 
Tristan Manalac
Joint pain anatomy medical concept
Pain
Lilly Follows Vertex Into Non-Opioid Pain With up to $1B SiteOne Buy
The acquisition of SiteOne provides a bit of diversification for Lilly, which has burrowed into the obesity and diabetes space with mega-blockbuster tirzepatide and several follow-on molecules.
May 27, 2025
 · 
2 min read
 · 
Annalee Armstrong
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS